Accueil › Cancer (tous types) › Virginie › Arlington
Essais cliniques pour Cancer (tous types) à Arlington, VA
48 études pour Cancer (tous types) recherchent des participants dans et autour de Arlington (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Recrutement en coursPhase 1/2
- NEXT Virginia, Fairfax · à 11 mi
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Recrutement en coursPhase 2
- Next Virginia /ID# 279684, Fairfax · à 11 mi
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Recrutement en coursPhase 2
- Virginia Cancer Specialists ( Site 1102), Fairfax · à 11 mi
A Study of ASP3082 in Adults With Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · à 11 mi
REC-7735 in Participants With Solid Tumors
Recrutement en coursPhase 1/2
- NEXT Virginia, Fairfax · à 11 mi
Registry Study for Radiation Therapy Outcomes
Recrutement en coursÉtude observationnelle
- Inova Schar Cancer Institute, Fairfax · à 11 mi
A Study of PHN-012 in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1
- PHN-012-001 Site, Fairfax · à 11 mi
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Recrutement en coursPhase 3
- Inova Schar Cancer Institute, Fairfax · à 11 mi
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology, Fairfax · à 11 mi
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Recrutement en coursPhase 3
- Inova Schar Cancer Institute Clinical Trials, Fairfax · à 11 mi
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Recrutement en coursPhase 3
- Virginia Cancer Specialists - Fairfax /ID# 280710, Fairfax · à 11 mi
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Recrutement en coursPhase 1/2
- NEXT Oncology Virginia, Fairfax · à 11 mi
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Recrutement en coursPhase 2
- Inova Schar Cancer Institute, Fairfax · à 11 mi
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Recrutement en coursPhase 1
- NEXT Virginia ( Site 0054), Fairfax · à 11 mi
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Recrutement en coursPhase 1
- Investigational Site number: 404, Fairfax · à 11 mi
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Recrutement en coursPhase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · à 11 mi
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology, Fairfax · à 11 mi
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Recrutement en coursPhase 3
- USO - Virginia Cancer Specialists, Fairfax · à 11 mi
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Recrutement en coursPhase 1
- NEXT Oncology, Fairfax · à 11 mi
Project: Every Child for Younger Patients With Cancer
Recrutement en coursÉtude observationnelle
- Inova Fairfax Hospital, Falls Church · à 4 mi
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
Recrutement en coursPhase 1
- NEXT Oncology Virginia, Fairfax · à 11 mi
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology Virginia, Fairfax · à 11 mi
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Recrutement en coursPhase 2
- 522, Fairfax · à 11 mi
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1
- Virginia Cancer Specialists, Fairfax · à 11 mi
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Recrutement en coursPhase 1
- Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax · à 11 mi
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Recrutement en coursPhase 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · à 11 mi
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · à 11 mi
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · à 11 mi
Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center
Recrutement en coursVolontaires sains bienvenus
- Inova Schar Cancer Institute, Fairfax · à 11 mi
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Recrutement en coursPhase 1/2
- NEXT Oncology Virginia, Fairfax · à 11 mi
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- NEXT, Fairfax · à 11 mi
Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
Recrutement en cours
- Inova Schar Cancer - Saville Cancer Screening and Prevention Center, Fairfax · à 11 mi
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Recrutement en coursPhase 1
- Research Site, Fairfax · à 11 mi
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Recrutement en coursPhase 2/3
- Virginia Cancer Specialists - Fairfax /ID# 275071, Fairfax · à 11 mi
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology Virginia, Fairfax · à 11 mi
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Recrutement en coursPhase 1/2
- NEXT Virginia, Fairfax · à 11 mi
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology - Virginia, Fairfax · à 11 mi
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology Virginia, Fairfax · à 11 mi
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Recrutement en coursPhase 1/2
- NEXT Oncology, Fairfax · à 11 mi
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Virginia, Fairfax · à 11 mi
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Recrutement en coursPhase 1
- NEXT Virigina, Fairfax · à 11 mi
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Recrutement en coursPhase 1
- Virginia Cancer Specialists, Fairfax · à 11 mi
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Recrutement en coursPhase 1/2
- Virginia Cancer Specialists, Fairfax · à 11 mi
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Recrutement en coursPhase 1/2
- NEXT Virginia, Fairfax · à 11 mi
A Study in Patients With Advanced Cancers
Recrutement en coursPhase 1/2
- NEXT Oncology Virginia, Fairfax · à 11 mi
Essais pour Cancer (tous types) dans d'autres villes
- Houston, TX121 études
- New York City, NY110 études
- Boston, MA86 études
- Los Angeles, CA73 études
- Nashville, TN65 études
- Philadelphia, PA59 études
- Durham, NC58 études
- Washington, DC58 études
- Chicago, IL51 études
- Seattle, WA49 études
- Atlanta, GA49 études
- St. Louis, MO46 études
Autres études à Arlington
- Cancer du poumon non à petites cellules104 études
- Cancer métastatique53 études
- Cancer colorectal52 études
- Cancer du sein46 études
- Cancer de l'ovaire46 études
- Cancer du poumon41 études
- Cancer de l'endomètre39 études
- Cancer du pancréas33 études
- Carcinome épidermoïde de la tête et du cou26 études
- Cancer bronchique à petites cellules23 études
- Cancer du sein triple négatif20 études
- Cancer de l'estomac20 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.